WO2000015152A1 - A bioabsorbable, layered composite material for guided bone tissue regeneration - Google Patents

A bioabsorbable, layered composite material for guided bone tissue regeneration Download PDF

Info

Publication number
WO2000015152A1
WO2000015152A1 PCT/EP1999/006682 EP9906682W WO0015152A1 WO 2000015152 A1 WO2000015152 A1 WO 2000015152A1 EP 9906682 W EP9906682 W EP 9906682W WO 0015152 A1 WO0015152 A1 WO 0015152A1
Authority
WO
WIPO (PCT)
Prior art keywords
implant
bone
bioabsorbable
plate
layer
Prior art date
Application number
PCT/EP1999/006682
Other languages
French (fr)
Other versions
WO2000015152B1 (en
Inventor
Pertti Törmälä
Minna Kellomaki
Timo Waris
Original Assignee
Bionx Implants Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionx Implants Oy filed Critical Bionx Implants Oy
Priority to CA002343333A priority Critical patent/CA2343333A1/en
Priority to EP99969010A priority patent/EP1112047B1/en
Priority to DE69923696T priority patent/DE69923696T2/en
Priority to AT99969010T priority patent/ATE288720T1/en
Priority to AU59761/99A priority patent/AU768132B2/en
Priority to JP2000569738A priority patent/JP2002524199A/en
Publication of WO2000015152A1 publication Critical patent/WO2000015152A1/en
Publication of WO2000015152B1 publication Critical patent/WO2000015152B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2875Skull or cranium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/84Fasteners therefor or fasteners being internal fixation devices
    • A61B17/86Pins or screws or threaded wires; nuts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • A61F2002/285Fixation appliances for attaching bone substitute support means to underlying bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30011Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30032Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in absorbability or resorbability, i.e. in absorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30448Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30451Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30461Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30971Laminates, i.e. layered products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time

Definitions

  • the present invention describes a bioabsorbable layered surgical implant comprising two components.
  • One component is a solid plate of bioabsorbable polymer and the other is a web made of bioabsorbable fibers. These implants guide and enhance bone healing and protect the soft tissues beneath the healing bone. These implants are particularly useful in cranioplasty.
  • bone tissue grafts have been made, for example, as allografts from canine bone, human bone, decalcified bone, pericranium, and as autografts from the tibia, rib and crista iliac. See Zeiss Index and History of Plastic Surgery 900 BC- 1863 AD Baltimore, Williams & Wilkins, 1977, vol 1 , pp 51 -52; Chase S.W., Herndon C.H., The fate of autogenous and homogenous bone grafts: A historical review, Journal of Bone Joint Surgery 37 A, 1955, pp.
  • biostable materials can be solved with implants made of bioabsorbable polymers, which cause fewer inflammatory reactions.
  • the bioabsorbable implants are also suitable for children, because these implants resorb totally and the degradation products disappear from the body via metabolic routes.
  • these materials can be chosen to degrade quickly enough so that the growth of the child ' s cranium is not restricted, thereby obviating the need for a second operation.
  • bioabsorbable plates Even with bioabsorbable plates, however, there is a desire to effect quicker bone regeneration and healing.
  • the implant described in more detail in this application comprises two components.
  • One component is a solid plate of a bioabsorbable polymer and the other is a web, typically made of bioabsorbable fibers.
  • These implants have a surface structure that promotes bone growth on one side and prevents tissue irritation on the other.
  • implants of the present invention enhance bone healim - and protect the soft tissues beneath the healing bone and around the implant.
  • Figure 1 is a cross-sectional schematic view of one embodiment of the implant of the present invention covering a cranial defect.
  • This invention relates to a bioabsorbable bone growth guiding implant, such as a cranioplasty implant, that adheres to bone, enhances growth and healing of the bone, and protects soft tissues, such as the brain, beneath the implant.
  • the implant is manufactured by totally or partially joining together: (a) a solid and stiff bioabsorbable plate; and (b) a flexible and porous bioabsorbable web. These components are referred to herein as the (a) plate and
  • both layers can be made of a bioabsorbable homopolymer, bioabsorbable copolymer, bioabsorbable polymer blend or polymer-based composite. These layers can be made of either the same or different materials, depending upon the particular application at hand. Possible biodegradable polymers to be used for the implant of the present invention are listed, e.g., in WO 96/41596, the entire disclosure of which is incorporated herein by way of this reference.
  • the implant can be implanted over the defect 7 in a bone 4, such as the cranium, to protect the tissues 6 inside or below the defect 7, such as those inside the skull, from being" damaged.
  • the implant 1 comprises two layers, the rigid plate layer 2 and the web layer 3.
  • the plate layer 2 determines the shape and size of the implant and has enough strength and stiffness to act as a protective shield for the tissue 6. It may be specially cut and shaped to easily and closely cover the defect 7 and the surrounding bone 4. In a preferred embodiment of the present invention, the top side of the plate layer 2 is smooth to avoid the irritation of surrounding tissues which could cause an adverse reaction in the patient.
  • the plate layer 2 may be made from any of the prior art biodegradable materials using techniques known in plastics technology, including extrusion, injection molding and/or solid state deformation, or pressing to the desired shape with or without heat. It is also possible to mechanically machine the plate layer to the desired shape. It is also possible to use a combination of techniques, for example, using machining to form a curved implant from an extruded sheet.
  • the thickness of the plate layer 2 will generally range from about 0.05 mm to about 3 mm, preferably from about 0.2 mm to about 1.5 mm. It is preferable to make the plate layer 2 as thin as possible, while still retaining enough rigidity to adequately protect the soft tissue 6.
  • the thickness and other dimensions of the plate layer 2 (and implant 1) will depend on the size of the defect 7 to be covered, as well as the curvature of the surrounding bone 4 and, therefore, can vary greatly.
  • the web layer 3 is located below the plate layer 2 and above the bone 4 and the defect
  • the web layer 3 directs and enhances bone growth by providing a porous surface along which and into which the bone tissue can grow and spread.
  • the web layer 3 is therefore located on the side of the implant that is placed against the bone 4 and the defect 7.
  • the sizes of the pores in the web structure are controlled so as to favor " bone growth.
  • the favorable pore size for promoting bone growth along the fibrous web layer 3 of the present invention has been discovered to be between about 30 ⁇ m and about 1000 ⁇ m.
  • bone cells are not able to easily grow into pores smaller than about 30 ⁇ m.
  • the pore size is between about 50 ⁇ m and about 400 ⁇ m, which best promotes bone growth.
  • the plate layer 2 and the web layer 3 are only partially or loosely attached to each other.
  • the porous structure of the web layer can be manufactured from biodegradable fibers using any known methods from mechanical textile and plastics technology.
  • the thickness of the fibers can vary from about 1 ⁇ m to about 200 ⁇ m. In a preferred embodiment of the invention, the fiber thickness is between about 5 ⁇ m and about 150 ⁇ m.
  • Structures suitable for the web component of this implant can be, for example, a cloth, a narrow fabric, a knit, a weave, a braid, or a web. In any case, the structure should be porous with pore size from about 30 ⁇ m to about 1000 ⁇ m, preferably between about 50 ⁇ m to about 400 ⁇ m.
  • the web component can be manufactured using one type of fiber, for example polyglycolide or polylactide fibers. It is also possible to make the web using two or more—— different types of fibers depending upon the particular application and desired physical characteristics of the implant.
  • the web layer 3 is made of biodegradable polymer that degrades faster than the polymer used for the plate layer 2.
  • the web layer 3 degrades before the plate layer 2, allowing the bone to develop a more dense structure and attach to the surface of the plate before the plate disintegrates.
  • the plate component remains and gives the desired strength, shape, and protection to the defect, while the regenerating bone increases its strength and density.
  • bone may also cover the other side of the implant by growing on top of it, starting from the edges of the plate. Regardless, the implant finally resorbs, having been replaced with new bone and or connective tissue. Resorption products disappear from the body via metabolic routes.
  • the bone defect is covered or filled in by the patient's own regenerated bone.
  • the implant 1 can be fixed to the bone 4 with various attachment techniques known in the art, such as bioabsorbable sutures, bioabsorbable tacks, minitacks or microtacks, or bioabsorbable screws, depending on the implantation site and size of the implant.
  • the implant 1 is attached to the bone 4 with small bioabsorbable screws 5.
  • the layers of the implant 1 may be joined to each other, e.g., by welding, as is described in a patent application to Paasimaa S., Kellomaki M., and T ⁇ rmala P., entitled "A bioabsorbable 2-dimensional multi-layer composite device and its manufacturing method," which is being filed concurrently herewith, or they can be glued, hot-pressed, ultrasonically welded or welded with some other technique.
  • the layers of the implant 1 may remain separated before implantation, and joined during surgery by stitching them simultaneously-a. cover the cranial defect. They can also be joined together by attaching them to the bone using biodegradable tacks, minitacks, microtacks or miniscrews.
  • the implant 1 may contain various additives and modifiers that improve the processability of polymer, such as plasticizers and antioxidants.
  • the components of the implant can also contain one or more bioactive, bone growth stimulating, or pharmaceutically active agents, like antibiotics, growth hormones or anticoagulants.
  • any bioceramic or bioactive glass e.g., in the form of powder, flakes or fibers, which has been found to enhance bone healing, can be used as an additive.
  • Typical examples of such bioceramics and bioactive glasses useful in this invention hydroxyapatite, tricalcium phosphate and other calcium phosphates, Bioglass® (available from Research Center, University of Florida, Gainsville, Fla., USA), Ceravital®, Alumina, Zirconia, Bioactive gel-glass and other bioactive glasses.
  • the web layer is embedded with gel or paste containing bone growth factor(s), like NOVOS (made by and available from Stryker Biotech, Natic, MA, USA), which comprises osteoconductive type I bone collagen and osteogenic protein 1.
  • NOVOS made by and available from Stryker Biotech, Natic, MA, USA
  • Example 1 The repair of a 10 x 10 mm defect in the skull of adult New Zealand rabbits was carried out using each of the following five methods (A. through E.) to compare the rate of bone regeneration for each of those methods.
  • a polylactide sheet of thickness 0.4 mm was prepared by extrusion of poly- D,L-lactide (D/L ratio 96/4), and a piece of size 15 x 15 mm was cut out from it, the corners rounded off and the plate bent to the desired convex form.
  • the plate was fixed over the defect with DEXON stitches (available from Davis & Geek, USA) extending into the surrounding periosteum and the soft tissues were closed over it.
  • a piece of 0.15 mm thick polyglycolide membrane having a fibrous surface (Biofix®, available from and manufactured by Bionx Implants Ltd., Tampere, Finland) was cut to the shape of the plate described in method B, above, and placed over the defect with its fiber side towards the bone and defect.
  • the membrane and the plate were fixed in position with DEXON stitches extending into the surrounding periosteum and the soft tissues closed over them.
  • a piece of fiber web composed of polyglycolide fibers and bioactive glass fibers (composition of Na 2 0, 6 mol. %; K 2 0, 7.9 mol. %; MgO , 7.7 mol. %; CaO, 22.1 mol. %; P 2 0 5 , 1.7 mol. %; and Si0 2 , 54.6 mol. %) was cut to the shape of the plate as described in method C above, and placed over the defect with a plate (as described in method B, above ⁇ m top of it. The plate and the web were fixed in position with DEXON stitches extending into the surrounding periosteum and the soft tissues were closed over the plate.
  • rTGF- ⁇ 1 recombinant growth factor
  • Traumatology was mechanically mixed into a sterile 85/15 (wt. %/wt. %) blend consisting, respectively, of oligo L-lactate and copolymer of e-caprolactone and D,L-lactide (60/40 in D/L).
  • the paste was painted onto the fibrous surface of a membrane as described in method C, above, and the membrane was then placed in position with the surface containing growth factor and polymer blend carrier towards the bone (and the defect).
  • a plate of the kind described in method B, above, was placed on top of it, the membrane and the plate were fixed in position with DEXON stitches extending into the surrounding periosteum, and the tissues were closed over the plate.
  • Example 2 The repair of a 10 x 10 mm defect in the skull of adult New Zealand rabbits was carried out using the following 2 methods, to compare the rate of bone regeneration for those methods.
  • a stiff plate was prepared by extrusion of poly(ortho ester) (a rigid copolymer of diketene acetal and 60:40 molar ratio of rigid and flexible diols manufactured as described in: Heller J., Poly(ortho esters), Advances in Polymer Science 107: 41-92, 1993, the entire disclosure of which is incorporated herein by way of this reference) to a thickness of 0.5 mm, and cut into pieces of size 15 x 15 mm. The corners of the plate were rounded off and the pieces bent to the desired convex form under heat. As shown in Figure 1 , the plate was fixed to the bone surrounding the defect using poly(ortho ester) mini-studs and the soft tissues were closed over the plate.
  • poly(ortho ester) a rigid copolymer of diketene acetal and 60:40 molar ratio of rigid and flexible diols manufactured as described in: Heller J., Poly(ortho esters), Advances in Polymer Science 107:

Abstract

This invention describes a rigid layered composite material (1) comprising a bioabsorbable plate layer (2) and a bioabsorbable web layer (3) for guided bone tissue regeneration, particularly suited for use in the treatment of cranial bone defects (7).

Description

A BIOABSORBABLE, LAYERED COMPOSITE MATERIAL FOR GUIDED BONE TISSUE REGENERATION
BACKGROUND OF THE INVENTION
The present invention describes a bioabsorbable layered surgical implant comprising two components. One component is a solid plate of bioabsorbable polymer and the other is a web made of bioabsorbable fibers. These implants guide and enhance bone healing and protect the soft tissues beneath the healing bone. These implants are particularly useful in cranioplasty.
Guided bone regeneration by means of implants has a long history, especially in cranioplasty, where there exists a great need to prevent damage to the brain by covering holes and other defects in cranial bone. The materials used to effect guided bone regeneration, such as would occur in cranioplasty, must meet several criteria. They must have, for example, good biocompatibility and high mechanical strength. Further, they should not cause bone erosion.
In the past, bone tissue grafts have been made, for example, as allografts from canine bone, human bone, decalcified bone, pericranium, and as autografts from the tibia, rib and crista iliac. See Zeiss Index and History of Plastic Surgery 900 BC- 1863 AD Baltimore, Williams & Wilkins, 1977, vol 1 , pp 51 -52; Chase S.W., Herndon C.H., The fate of autogenous and homogenous bone grafts: A historical review, Journal of Bone Joint Surgery 37 A, 1955, pp. 809-841 ; Prolo D.J., Cranial defects and cranioplasty, in Wilkins RH, Rengachary SS (eds): Neurosurgery, New York, McGraw-Hill, 1984, pp 1647-1656; Grant F.C., Norcross N.C., Repair of Cranial Defects By Cranioplasty, Annual Surgery vol. 1 10, 1939, pp. 488-512; Reeves D.L., Cranioplasty, Springfield IL, Charles C. Thomas, 1950; and
Woolf J.I., Walker A.E., Cranioplasty, Collective review, International Abstracts Surgery 81 , 1945, pp. 1 -23, the entire disclosures of each of which are incorporated herein by way of-Oas reference. However, there are problems associated with the use of bone tissue grafts. If the patient's own bone is used as a graft, a surgeon must perform an additional, traumatic operation to take the bone sample. If the bone graft is taken from another person or animal bone is used, viral contaminations or immunological problems are possible, even if the graft is treated to make it compatible with the patient's tissue.
Additionally, man-made biostable materials have been studied in cranioplasty applications, such as cellulose fibers, aluminum, gold, titanium, stainless steel, poly methyl methacrylate (PMMA), polyethylene and silicone. See, Habal M.B.. Leake D.L., Maniscako J.E., A new method for reconstruction of major defects in the cranial vault, Surgery
Neurology 6, 1976, pp. 137- 138; Karvounis P.C, Chiu J., Sabin H., The use of prefabricated polyethylene plate for cranioplasty, Journal of Trauma 10, 1970, pp. 249-254; and Black S.P.W., Reconstruction of the supraorbital ridge using aluminum, Surgery Neurology 9, 1978, pp. 121-128, the entire disclosures of each of which are incorporated herein by way of this reference. However, the clinical use of most of these materials has been rejected due to severe tissue reactions. Further, biostable implants are particularly ill-suited for cranioplasty in children because a biostable implant prevents the immature skull bone from growing to adult size and, therefore, the implant needs to be removed in a second surgical procedure. Many of the problems of biostable materials can be solved with implants made of bioabsorbable polymers, which cause fewer inflammatory reactions. The bioabsorbable implants are also suitable for children, because these implants resorb totally and the degradation products disappear from the body via metabolic routes. Moreover, these materials can be chosen to degrade quickly enough so that the growth of the child's cranium is not restricted, thereby obviating the need for a second operation. Even with bioabsorbable plates, however, there is a desire to effect quicker bone regeneration and healing.
BRIEF SUMMARY OF THE INVENTION Thus, it is a goal of the present invention to provide an implant, particularly for cranioplasty, that is bioabsorbable, yet strong enough to protect soft tissue, such as the brain, during the healing period.
It is further a goal of the present invention to provide an implant, particularly for cranioplasty, that may be easily shaped or formed and applied over a defect in a bone, such as the cranium.
It is further a goal of the present invention to provide an implant, particularly for cranioplasty, that will promote quick bone regeneration, thereby shortening the healing period.
It is further a goal of the present invention to provide an implant, particularly for cranioplasty, that will degrade quickly enough so as not to restrict the natural growth in children of the bone under repair.
These and other goals are met with the present invention, comprising a rigid and tough, yet easily shaped, layered bioabsorbable implant for guided bone tissue regeneration, which may be used as a bioabsorbable surgical cranioplasty implant. The implant described in more detail in this application comprises two components. One component is a solid plate of a bioabsorbable polymer and the other is a web, typically made of bioabsorbable fibers. These implants have a surface structure that promotes bone growth on one side and prevents tissue irritation on the other. Thus, implants of the present invention enhance bone healim - and protect the soft tissues beneath the healing bone and around the implant.
BRIEF DESCRIPTION OF THE DRAWINGS The present invention will be more fully described in conjunction with the accompanying diagram wherein:
Figure 1 is a cross-sectional schematic view of one embodiment of the implant of the present invention covering a cranial defect.
DETAILED DESCRIPTION OF THE INVENTION
This invention relates to a bioabsorbable bone growth guiding implant, such as a cranioplasty implant, that adheres to bone, enhances growth and healing of the bone, and protects soft tissues, such as the brain, beneath the implant. The implant is manufactured by totally or partially joining together: (a) a solid and stiff bioabsorbable plate; and (b) a flexible and porous bioabsorbable web. These components are referred to herein as the (a) plate and
(b) web layers. Both layers can be made of a bioabsorbable homopolymer, bioabsorbable copolymer, bioabsorbable polymer blend or polymer-based composite. These layers can be made of either the same or different materials, depending upon the particular application at hand. Possible biodegradable polymers to be used for the implant of the present invention are listed, e.g., in WO 96/41596, the entire disclosure of which is incorporated herein by way of this reference.
With reference to Figure 1 , which demonstrates an embodiment of the present invention, the implant can be implanted over the defect 7 in a bone 4, such as the cranium, to protect the tissues 6 inside or below the defect 7, such as those inside the skull, from being" damaged. The implant 1 comprises two layers, the rigid plate layer 2 and the web layer 3.
The plate layer 2 determines the shape and size of the implant and has enough strength and stiffness to act as a protective shield for the tissue 6. It may be specially cut and shaped to easily and closely cover the defect 7 and the surrounding bone 4. In a preferred embodiment of the present invention, the top side of the plate layer 2 is smooth to avoid the irritation of surrounding tissues which could cause an adverse reaction in the patient.
The plate layer 2 may be made from any of the prior art biodegradable materials using techniques known in plastics technology, including extrusion, injection molding and/or solid state deformation, or pressing to the desired shape with or without heat. It is also possible to mechanically machine the plate layer to the desired shape. It is also possible to use a combination of techniques, for example, using machining to form a curved implant from an extruded sheet.
The thickness of the plate layer 2 will generally range from about 0.05 mm to about 3 mm, preferably from about 0.2 mm to about 1.5 mm. It is preferable to make the plate layer 2 as thin as possible, while still retaining enough rigidity to adequately protect the soft tissue 6. The thickness and other dimensions of the plate layer 2 (and implant 1) will depend on the size of the defect 7 to be covered, as well as the curvature of the surrounding bone 4 and, therefore, can vary greatly. The web layer 3 is located below the plate layer 2 and above the bone 4 and the defect
7. It has been found, surprisingly, that the web layer 3 directs and enhances bone growth by providing a porous surface along which and into which the bone tissue can grow and spread. The web layer 3 is therefore located on the side of the implant that is placed against the bone 4 and the defect 7. The sizes of the pores in the web structure are controlled so as to favor" bone growth.
The favorable pore size for promoting bone growth along the fibrous web layer 3 of the present invention has been discovered to be between about 30μm and about 1000 μm. Typically, bone cells are not able to easily grow into pores smaller than about 30 μm. With pore sizes larger than about 1000 μm, bone growth is slower because there is less physical structure to which the bone cells can adhere themselves during regeneration. Most preferably, the pore size is between about 50 μm and about 400 μm, which best promotes bone growth. In order to maintain the porosity of the web layer during the manufacturing of the implant 1 , in a preferred embodiment of the present invention, the plate layer 2 and the web layer 3 are only partially or loosely attached to each other. This leaves a high degree of porosity in the surface structure of the web layer 3, which promotes rapid bone regeneration. The upper surface of the web layer 3 should be in contact with the plate layer 2, but not totally merged with the surface of the plate layer 2, thus leaving the web layer 3 porous.
The porous structure of the web layer can be manufactured from biodegradable fibers using any known methods from mechanical textile and plastics technology. The thickness of the fibers can vary from about 1 μm to about 200 μm. In a preferred embodiment of the invention, the fiber thickness is between about 5μm and about 150μm. Structures suitable for the web component of this implant can be, for example, a cloth, a narrow fabric, a knit, a weave, a braid, or a web. In any case, the structure should be porous with pore size from about 30 μm to about 1000 μm, preferably between about 50 μm to about 400 μm. The web component can be manufactured using one type of fiber, for example polyglycolide or polylactide fibers. It is also possible to make the web using two or more—— different types of fibers depending upon the particular application and desired physical characteristics of the implant.
In a preferred embodiment of the present invention, the web layer 3 is made of biodegradable polymer that degrades faster than the polymer used for the plate layer 2. Thus, the web layer 3 degrades before the plate layer 2, allowing the bone to develop a more dense structure and attach to the surface of the plate before the plate disintegrates. The plate component remains and gives the desired strength, shape, and protection to the defect, while the regenerating bone increases its strength and density. Simultaneously, but as a slower process, bone may also cover the other side of the implant by growing on top of it, starting from the edges of the plate. Regardless, the implant finally resorbs, having been replaced with new bone and or connective tissue. Resorption products disappear from the body via metabolic routes. In the end, the bone defect is covered or filled in by the patient's own regenerated bone. The implant 1 can be fixed to the bone 4 with various attachment techniques known in the art, such as bioabsorbable sutures, bioabsorbable tacks, minitacks or microtacks, or bioabsorbable screws, depending on the implantation site and size of the implant. In Figure 1, the implant 1 is attached to the bone 4 with small bioabsorbable screws 5.
The layers of the implant 1 may be joined to each other, e.g., by welding, as is described in a patent application to Paasimaa S., Kellomaki M., and Tόrmala P., entitled "A bioabsorbable 2-dimensional multi-layer composite device and its manufacturing method," which is being filed concurrently herewith, or they can be glued, hot-pressed, ultrasonically welded or welded with some other technique. The layers of the implant 1 may remain separated before implantation, and joined during surgery by stitching them simultaneously-a. cover the cranial defect. They can also be joined together by attaching them to the bone using biodegradable tacks, minitacks, microtacks or miniscrews. These methods can also be used to attach the implant 1 with other prejoined components. The implant 1 may contain various additives and modifiers that improve the processability of polymer, such as plasticizers and antioxidants. The components of the implant can also contain one or more bioactive, bone growth stimulating, or pharmaceutically active agents, like antibiotics, growth hormones or anticoagulants. Also, any bioceramic or bioactive glass (e.g., in the form of powder, flakes or fibers), which has been found to enhance bone healing, can be used as an additive. Typical examples of such bioceramics and bioactive glasses useful in this invention: hydroxyapatite, tricalcium phosphate and other calcium phosphates, Bioglass® (available from Research Center, University of Florida, Gainsville, Fla., USA), Ceravital®, Alumina, Zirconia, Bioactive gel-glass and other bioactive glasses. According to a particularly advantageous embodiment of the present invention, the web layer is embedded with gel or paste containing bone growth factor(s), like NOVOS (made by and available from Stryker Biotech, Natic, MA, USA), which comprises osteoconductive type I bone collagen and osteogenic protein 1. These growth factors induce and further stimulate the bone growth under the cranioplasty, thereby intensifying bone formation and healing.
After the description above of the present invention and certain specific embodiments thereof, it will be readily apparent to those skilled in the art that many variations and modifications may be made to the present invention without departing from the spirit and scope thereof. The following non-limiting examples further demonstrate various embodiments of the present invention.
Example 1. The repair of a 10 x 10 mm defect in the skull of adult New Zealand rabbits was carried out using each of the following five methods (A. through E.) to compare the rate of bone regeneration for each of those methods.
A. The soft tissues were closed over the defect.
B. A polylactide sheet of thickness 0.4 mm was prepared by extrusion of poly- D,L-lactide (D/L ratio 96/4), and a piece of size 15 x 15 mm was cut out from it, the corners rounded off and the plate bent to the desired convex form. The plate was fixed over the defect with DEXON stitches (available from Davis & Geek, USA) extending into the surrounding periosteum and the soft tissues were closed over it.
C. A piece of 0.15 mm thick polyglycolide membrane having a fibrous surface (Biofix®, available from and manufactured by Bionx Implants Ltd., Tampere, Finland) was cut to the shape of the plate described in method B, above, and placed over the defect with its fiber side towards the bone and defect. The plate described in method B, above, was placed on top of the defect and the membrane. The membrane and the plate were fixed in position with DEXON stitches extending into the surrounding periosteum and the soft tissues closed over them.
D. A piece of fiber web composed of polyglycolide fibers and bioactive glass fibers (composition of Na20, 6 mol. %; K20, 7.9 mol. %; MgO , 7.7 mol. %; CaO, 22.1 mol. %; P205, 1.7 mol. %; and Si02, 54.6 mol. %) was cut to the shape of the plate as described in method C above, and placed over the defect with a plate (as described in method B, above τm top of it. The plate and the web were fixed in position with DEXON stitches extending into the surrounding periosteum and the soft tissues were closed over the plate.
E. 50 μg recombinant growth factor (rTGF-β 1 , recombinant transgenic growth factor, available from and delivered by Helsinki University, Dept. Of Orthopedics and
Traumatology) was mechanically mixed into a sterile 85/15 (wt. %/wt. %) blend consisting, respectively, of oligo L-lactate and copolymer of e-caprolactone and D,L-lactide (60/40 in D/L). The paste was painted onto the fibrous surface of a membrane as described in method C, above, and the membrane was then placed in position with the surface containing growth factor and polymer blend carrier towards the bone (and the defect). A plate of the kind described in method B, above, was placed on top of it, the membrane and the plate were fixed in position with DEXON stitches extending into the surrounding periosteum, and the tissues were closed over the plate.
Each procedure was performed in triplicate, and the animals were sacrificed after 12 weeks in all cases.
There occurred no bone growth in series A. In the case of series B, bone growth had proceeded to 40 percent of the defect area, but the defect was still partly filled with connective tissue in the center. Series C, D and E, which used implants according to the present invention, however, showed complete coverage of the defect by bone, although this was about 50 percent thinner in the center than at the edges in series C and 40 percent thinner in that respect in series D. In the series E, the new bone was only 30 percent thinner in the center of the defect than at the edges. Thus, with the implants of the present invention, it is possible to greatly increase the rate of cranial bone regeneration previously achieved with prior art biodegradable implants.
Example 2. The repair of a 10 x 10 mm defect in the skull of adult New Zealand rabbits was carried out using the following 2 methods, to compare the rate of bone regeneration for those methods.
A. A stiff plate was prepared by extrusion of poly(ortho ester) (a rigid copolymer of diketene acetal and 60:40 molar ratio of rigid and flexible diols manufactured as described in: Heller J., Poly(ortho esters), Advances in Polymer Science 107: 41-92, 1993, the entire disclosure of which is incorporated herein by way of this reference) to a thickness of 0.5 mm, and cut into pieces of size 15 x 15 mm. The corners of the plate were rounded off and the pieces bent to the desired convex form under heat. As shown in Figure 1 , the plate was fixed to the bone surrounding the defect using poly(ortho ester) mini-studs and the soft tissues were closed over the plate.
B. The inner surface of the plate described above in method A was moistened with a solvent, which made the surface of the plate tacky, and broken poly(ortho ester) fibers were sprinkled onto it so that they adhered to it and made the surface uneven and porous. Each series (A and B) comprised 12 animals, of which 4 were sacrificed after 3 weeks, 4 after 24 weeks and 4 after 48 weeks. No soft tissue inflammatory reactions were seen in either series at the end of the experiment. No new bone tissue was observed in series A after three weeks, but 10 percent of the area of the defect had been covered by new bone in series B. After 24 weeks a coverage of 90 percent had been achieved in series A and full coverage in series B, while after 48 weeks the underside of the implant had become fully— — ossified in both series and some bone had been formed on the upper surface. As shown in Fig. 1. the plate was fixed to the bone surrounding the defect using poly (ortho ester) (the same copolymer as described above in method A) mini-studs.

Claims

We claim: ΓÇö - ΓÇö
1. An at least partially bioabsorbable cranial implant comprising: a rigid plate layer of bioabsorbable material having upper and lower sides, a fibrous web layer of bioabsorbable material in at least partial contact with the lower side of the rigid plate layer.
2. The implant of claim 1 wherein the rigid plate layer comprises bioabsorbable homopolymer, copolymer, polymer blend, or polymer composite.
3. The implant of claim 1 wherein the fibrous web layer comprises bioabsorbable homopolymer, copolymer, polymer blend, or polymer composite.
4. The implant of claim 1 wherein the rigid plate layer and the fibrous web layer are made of the same material.
5. The implant of claim 1 wherein the material of the fibrous web layer bioabsorbs faster than the material of the rigid plate layer.
6. The implant of claim 1 wherein the fibrous web layer contains pores that are between 30╬╝m and 1000 ╬╝m in diameter.
7. The implant of claim 6 wherein the fibrous web layer contains pores that are between 50 ╬╝m and 400 ╬╝m in diameter.
8. The implant of claim 1 wherein the implant further comprises bioceramic glass. ^Γëñ.
9. The implant of claim 1 wherein the implant further comprises a bioactive agent.
10. A method for performing cranioplasty comprising the step of: at least partially attaching the implant of claim 1 to a defect in a cranium so that the fibrous web layer abuts the cranium.
PCT/EP1999/006682 1998-09-14 1999-09-10 A bioabsorbable, layered composite material for guided bone tissue regeneration WO2000015152A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002343333A CA2343333A1 (en) 1998-09-14 1999-09-10 A bioabsorbable, layered composite material for guided bone tissue regeneration
EP99969010A EP1112047B1 (en) 1998-09-14 1999-09-10 A bioabsorbable, layered composite material for guided bone tissue regeneration
DE69923696T DE69923696T2 (en) 1998-09-14 1999-09-10 BIOABSORBABLE LAYERED COMPOSITE FOR CONTROLLED BONE WEAVE GENERATION
AT99969010T ATE288720T1 (en) 1998-09-14 1999-09-10 BIOABSORBABLE LAYER COMPOSITE FOR CONTROLLED BONE TISSUE GENERATION
AU59761/99A AU768132B2 (en) 1998-09-14 1999-09-10 A bioabsorbable, layered composite material for guided bone tissue regeneration
JP2000569738A JP2002524199A (en) 1998-09-14 1999-09-10 Bioabsorbable layered composites for inductive bone tissue regeneration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,437 US6350284B1 (en) 1998-09-14 1998-09-14 Bioabsorbable, layered composite material for guided bone tissue regeneration
US09/152,437 1998-09-14

Publications (2)

Publication Number Publication Date
WO2000015152A1 true WO2000015152A1 (en) 2000-03-23
WO2000015152B1 WO2000015152B1 (en) 2000-05-25

Family

ID=22542915

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/006682 WO2000015152A1 (en) 1998-09-14 1999-09-10 A bioabsorbable, layered composite material for guided bone tissue regeneration

Country Status (9)

Country Link
US (1) US6350284B1 (en)
EP (1) EP1112047B1 (en)
JP (1) JP2002524199A (en)
AT (1) ATE288720T1 (en)
AU (1) AU768132B2 (en)
CA (1) CA2343333A1 (en)
DE (1) DE69923696T2 (en)
ES (1) ES2237968T3 (en)
WO (1) WO2000015152A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1738702A1 (en) * 2005-07-02 2007-01-03 Greater Glasgow Health Board Supra mucosal bone fixation
CN102028561A (en) * 2010-12-03 2011-04-27 南方医科大学 Basis cranii repairing body
WO2015117170A1 (en) * 2014-02-05 2015-08-13 Dietmar Sonnleitner Preliminarily bonded multilayer film for covering a bone defect site
WO2016019404A1 (en) * 2014-08-05 2016-02-11 Dietmar Sonnleitner Method for producing a multilayer film
EP3115025A1 (en) * 2015-07-08 2017-01-11 Skulle Implants OY Orthopedic implant
DE102019200003A1 (en) * 2018-01-02 2019-07-04 Shandong Branden Medical Device Co., Ltd. Porous bionic skull repair material and method of manufacture and use

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795242B2 (en) * 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
US7963997B2 (en) * 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US6884427B1 (en) * 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
FR2801191B1 (en) * 1999-11-19 2002-02-15 Proconcept PROTECTION DEVICE FOR NERVES AFTER SURGERY
US20050119694A1 (en) * 2000-05-19 2005-06-02 Jacobs Daniel I. Remotely anchored tissue fixation device and method
US6645226B1 (en) * 2000-05-19 2003-11-11 Coapt Systems, Inc. Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing
US7156862B2 (en) 2000-05-19 2007-01-02 Coapt Systems, Inc. Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing
US6485503B2 (en) * 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
US7172615B2 (en) * 2000-05-19 2007-02-06 Coapt Systems, Inc. Remotely anchored tissue fixation device
US7510566B2 (en) * 2000-05-19 2009-03-31 Coapt Systems, Inc. Multi-point tissue tension distribution device and method, a chin lift variation
WO2002015952A1 (en) * 2000-08-08 2002-02-28 Bioamide, Inc. Scaffolds for tissue engineered hair
US7192604B2 (en) * 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
FI117963B (en) * 2001-04-26 2007-05-15 Eija Marjut Pirhonen Material that replaces bone
US20060142765A9 (en) * 2001-10-15 2006-06-29 Dixon Robert A Vertebral implant for bone fixation or interbody use
US20030142676A1 (en) * 2002-01-25 2003-07-31 Raymond Zeisz Method and apparauts for admission control in packet switch
US20040068284A1 (en) * 2002-01-29 2004-04-08 Barrows Thomas H. Method for stimulating hair growth and kit for carrying out said method
US7311705B2 (en) * 2002-02-05 2007-12-25 Medtronic, Inc. Catheter apparatus for treatment of heart arrhythmia
NL1021137C2 (en) * 2002-07-23 2004-01-27 Fondel Finance B V Support element for attachment to bone.
US7066962B2 (en) * 2002-07-23 2006-06-27 Porex Surgical, Inc. Composite surgical implant made from macroporous synthetic resin and bioglass particles
DE60300277T2 (en) 2002-11-08 2006-01-12 Howmedica Osteonics Corp. Laser generated porous surface
US20060147332A1 (en) 2004-12-30 2006-07-06 Howmedica Osteonics Corp. Laser-produced porous structure
US8298292B2 (en) 2003-04-16 2012-10-30 Howmedica Osteonics Corp. Craniofacial implant
CN100586401C (en) 2003-04-16 2010-02-03 波雷克斯外科手术用品公司 Craniofacial implant
EP1644478A4 (en) * 2003-06-30 2008-07-23 Lifescan Inc Multi-staged absorbable nonwoven structures for culturing pancreatic cells
DE10347232A1 (en) * 2003-10-10 2005-05-12 Bego Semados Gmbh & Co Kg Arrangement for the regression of a periodontosis-related bone defect
WO2005041812A2 (en) * 2003-10-22 2005-05-12 Implant Brace, Inc. Implantable brace for a fracture and methods
JP5086642B2 (en) 2003-11-21 2012-11-28 オステオポア・インターナショナル・プライヴェート・リミテッド Bioabsorbable plug implant and method for bone tissue regeneration
US20050197699A1 (en) * 2004-02-10 2005-09-08 Jacobs Daniel I. Tissue repair apparatus and method
US20050209542A1 (en) * 2004-03-16 2005-09-22 Jacobs Daniel I Tissue approximation sling and method
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
US8012501B2 (en) * 2004-06-10 2011-09-06 Synthes Usa, Llc Flexible bone composite
AR050212A1 (en) * 2004-08-13 2006-10-04 Aderans Res Inst Inc ORGANOGENESIS FROM DISCELLED CELLS
WO2006033623A1 (en) * 2004-09-21 2006-03-30 Tigran Technologies Ab Method and device for improving the fixing of a prosthesis
US20060217813A1 (en) * 2005-03-22 2006-09-28 Posnick Jeffrey C Facial implant
CN103932746B (en) * 2005-04-26 2017-01-04 聚合-医药有限公司 The surgical implant that absorbable/biodegradable composite yarns and the character coming from this adjust
US8709023B2 (en) 2007-07-17 2014-04-29 Poly-Med, Inc. Absorbable / biodegradable composite yarn constructs and applications thereof
CA2625264C (en) 2005-10-13 2015-12-15 Synthes (U.S.A.) Drug-impregnated sleeve for a medical implant
DE102005054941A1 (en) * 2005-11-17 2007-05-31 Gelita Ag nerve
US20070148138A1 (en) * 2005-11-22 2007-06-28 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
TW200803877A (en) * 2005-11-22 2008-01-16 Aderans Res Inst Inc Hair grafts derived from plucked hair
US8728387B2 (en) 2005-12-06 2014-05-20 Howmedica Osteonics Corp. Laser-produced porous surface
US8460346B2 (en) * 2006-01-17 2013-06-11 Biodynamics Llc Craniotomy closures
US7833253B2 (en) 2006-01-17 2010-11-16 Biodynamics Llc Craniotomy closures and plugs
US20080221594A1 (en) * 2006-01-31 2008-09-11 Hamman Ned M Resorbable truss
US20070191848A1 (en) * 2006-02-01 2007-08-16 Zimmer Technology, Inc. Hydrogel bone plate spacer
EP1997521A4 (en) * 2006-03-17 2012-09-12 Hi Lex Corp Medical material
US9155646B2 (en) * 2006-04-27 2015-10-13 Brs Holdings, Llc Composite stent with bioremovable ceramic flakes
US20060287654A1 (en) * 2006-08-11 2006-12-21 Jeffrey Posnick Implant securing device and method
DE102006047248B4 (en) * 2006-10-06 2012-05-31 Celgen Ag Three-dimensional artificial callus distraction
US7985537B2 (en) * 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
JP5554002B2 (en) * 2008-03-10 2014-07-23 株式会社ジーシー Method for producing cartilage tissue regeneration sheet
US9387280B2 (en) * 2008-09-05 2016-07-12 Synovis Orthopedic And Woundcare, Inc. Device for soft tissue repair or replacement
WO2010045487A1 (en) * 2008-10-15 2010-04-22 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via internal implants
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
FR2939304B1 (en) * 2008-12-05 2012-03-30 Pierre Sabin CASE-INTERFACE ASSEMBLY FOR IMPLICATION IN A BONE WALL
TWI496566B (en) * 2008-12-30 2015-08-21 Ind Tech Res Inst Artificial dura biomedical device
FI20095084A0 (en) 2009-01-30 2009-01-30 Pekka Vallittu Composite and its use
US9439685B2 (en) * 2009-05-12 2016-09-13 Bullard Spine, Llc Multi-layer osteoinductive, osteogenic, and osteoconductive carrier
US8343225B2 (en) * 2009-06-05 2013-01-01 Linares Medical Devices, Llc Skull patch with durable plastic construction and undercut mount to existing skull perimeter
EP2453939B1 (en) * 2009-07-16 2013-10-23 Anatoli D. Dosta Bone implants
US8994666B2 (en) * 2009-12-23 2015-03-31 Colin J. Karpfinger Tactile touch-sensing interface system
US8444699B2 (en) * 2010-02-18 2013-05-21 Biomet Manufacturing Corp. Method and apparatus for augmenting bone defects
US8715356B2 (en) * 2010-04-13 2014-05-06 Biomet Manufacturing, Llc Prosthetic having a modular soft tissue fixation mechanism
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
EP3733099B1 (en) * 2011-02-28 2022-08-31 DePuy Synthes Products, Inc. Modular tissue scaffolds
US8673014B2 (en) * 2011-04-01 2014-03-18 Kls-Martin, L.P. Method of cranial repair and cranial repair implant molding device
KR200465805Y1 (en) 2011-08-17 2013-03-11 오해수 Membrane for implant
CN102499996A (en) * 2011-11-04 2012-06-20 无锡中科光远生物材料有限公司 Fibrous membrane for non-virus gene treatment and preparation method thereof
TWI590843B (en) 2011-12-28 2017-07-11 信迪思有限公司 Films and methods of manufacture
JP6049473B2 (en) * 2013-01-25 2016-12-21 京セラメディカル株式会社 Skull plate
US9044195B2 (en) 2013-05-02 2015-06-02 University Of South Florida Implantable sonic windows
EP3010560B1 (en) 2013-06-21 2020-01-01 DePuy Synthes Products, Inc. Films and methods of manufacture
WO2016154549A1 (en) * 2015-03-26 2016-09-29 University Of Iowa Research Foundation Cranioplasty plate
CN105105872A (en) * 2015-09-08 2015-12-02 哈尔滨工业大学 Skull replacing apparatus of 3D print and manufacturing method thereof
KR101684901B1 (en) * 2015-09-14 2016-12-12 한국기계연구원 scaffold of bone insertion type
CN105997294B (en) * 2016-05-03 2018-02-06 李泽福 The patch system and method for repairing and mending applied in a kind of operations on cranium and brain
JP2019516481A (en) 2016-05-18 2019-06-20 ユニバーシティー オブ アイオワ リサーチ ファンデーション Cranioplastic plate assembly with pivotable struts
US11090091B1 (en) 2018-01-03 2021-08-17 Advance Research System, Llc Cannulated endplate plunger assembly
CN109363804B (en) * 2018-11-29 2021-04-30 北京爱康宜诚医疗器材有限公司 Anchoring device
US11446163B1 (en) 2019-04-05 2022-09-20 Advanced Research Systems, LLC Cannulated endplate plunger
CA3165448A1 (en) 2019-12-20 2021-06-24 Tepha, Inc. Resorbable implants for reconstruction of bone defects

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186448A (en) * 1976-04-16 1980-02-05 Brekke John H Device and method for treating and healing a newly created bone void
WO1992010218A1 (en) * 1990-12-06 1992-06-25 W.L. Gore & Associates, Inc. Implantable bioabsorbable article
US5380328A (en) * 1993-08-09 1995-01-10 Timesh, Inc. Composite perforated implant structures
WO1995028900A1 (en) * 1994-04-27 1995-11-02 Axel Kirsch Covering system for defective points in bones and process for producing it
WO1998007384A1 (en) * 1996-08-19 1998-02-26 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049720B1 (en) 1980-10-09 1986-08-13 National Research Development Corporation Prosthesis comprising composite material
US4338926A (en) * 1980-11-21 1982-07-13 Howmedica, Inc. Bone fracture prosthesis with controlled stiffness
US4400833A (en) 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4778472A (en) * 1985-04-30 1988-10-18 Vitek, Inc. Implant for reconstruction of temporomanibular joint
US5013315A (en) * 1985-07-12 1991-05-07 Minnesota Mining And Manufacturing Company Semiabsorbable bone plate spacer
US4839215A (en) * 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
JPS6368155A (en) 1986-09-11 1988-03-28 グンゼ株式会社 Bone bonding pin
FI80605C (en) * 1986-11-03 1990-07-10 Biocon Oy Bone surgical biocomposite material
DE3644588C1 (en) 1986-12-27 1988-03-10 Ethicon Gmbh Implant and process for its manufacture
FI81498C (en) 1987-01-13 1990-11-12 Biocon Oy SURGICAL MATERIAL OCH INSTRUMENT.
FI85223C (en) 1988-11-10 1992-03-25 Biocon Oy BIODEGRADERANDE SURGICAL IMPLANT OCH MEDEL.
AU5154390A (en) * 1989-02-15 1990-09-05 Microtek Medical, Inc. Biocompatible material and prosthesis
US5108755A (en) 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
GB2273874A (en) 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix
DE4302709C1 (en) * 1993-02-01 1994-07-28 Kirsch Axel Cover device with cover membrane
WO1996000592A2 (en) 1994-06-28 1996-01-11 Board Of Regents, The University Of Texax System Biodegradable fracture fixation plates and uses thereof
US5489305A (en) * 1994-10-03 1996-02-06 Timesh, Inc. Mandibular prostheses
FI101933B (en) 1995-06-13 1998-09-30 Biocon Oy Joint prosthesis
US5916585A (en) * 1996-06-03 1999-06-29 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto biodegradable polymers
WO1998014134A2 (en) 1996-10-04 1998-04-09 Ethicon, Inc. Knitted surgical mesh
US6083522A (en) 1997-01-09 2000-07-04 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US5980540A (en) * 1997-04-11 1999-11-09 Kinamed, Inc. Perforated cover for covering spaces in the cranium and conforming to the shape of the cranium

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186448A (en) * 1976-04-16 1980-02-05 Brekke John H Device and method for treating and healing a newly created bone void
WO1992010218A1 (en) * 1990-12-06 1992-06-25 W.L. Gore & Associates, Inc. Implantable bioabsorbable article
US5380328A (en) * 1993-08-09 1995-01-10 Timesh, Inc. Composite perforated implant structures
WO1995028900A1 (en) * 1994-04-27 1995-11-02 Axel Kirsch Covering system for defective points in bones and process for producing it
WO1998007384A1 (en) * 1996-08-19 1998-02-26 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1738702A1 (en) * 2005-07-02 2007-01-03 Greater Glasgow Health Board Supra mucosal bone fixation
CN102028561A (en) * 2010-12-03 2011-04-27 南方医科大学 Basis cranii repairing body
WO2015117170A1 (en) * 2014-02-05 2015-08-13 Dietmar Sonnleitner Preliminarily bonded multilayer film for covering a bone defect site
CN106029008A (en) * 2014-02-05 2016-10-12 迪特马尔·松莱特纳 preliminarily bonded multilayer film for covering a bone defect site
CN106659568A (en) * 2014-08-05 2017-05-10 迪特马尔·松莱特纳 Method for producing a multilayer film
WO2016019404A1 (en) * 2014-08-05 2016-02-11 Dietmar Sonnleitner Method for producing a multilayer film
US10624747B2 (en) 2014-08-05 2020-04-21 Dietmar SONNLEITNER Method for producing a multilayer film
WO2017005637A1 (en) * 2015-07-08 2017-01-12 Skulle Implants Oy Orthopedic implant
AU2016290506A1 (en) * 2015-07-08 2018-03-01 Skulle Implants Oy Orthopedic implant
CN107847326A (en) * 2015-07-08 2018-03-27 斯卡勒植入物公司 Orthopedic implants
AU2016290506B2 (en) * 2015-07-08 2018-08-02 Skulle Implants Oy Orthopedic implant
EP3115025A1 (en) * 2015-07-08 2017-01-11 Skulle Implants OY Orthopedic implant
US11013603B2 (en) 2015-07-08 2021-05-25 Skulle Implants Oy Orthopedic implant
DE102019200003A1 (en) * 2018-01-02 2019-07-04 Shandong Branden Medical Device Co., Ltd. Porous bionic skull repair material and method of manufacture and use
DE102019200003B4 (en) * 2018-01-02 2020-07-02 Shandong Branden Medical Device Co., Ltd. Porous bionic skull repair material and manufacturing method and use

Also Published As

Publication number Publication date
EP1112047A1 (en) 2001-07-04
JP2002524199A (en) 2002-08-06
EP1112047B1 (en) 2005-02-09
CA2343333A1 (en) 2000-03-23
DE69923696D1 (en) 2005-03-17
AU768132B2 (en) 2003-12-04
DE69923696T2 (en) 2006-01-12
WO2000015152B1 (en) 2000-05-25
AU5976199A (en) 2000-04-03
ES2237968T3 (en) 2005-08-01
ATE288720T1 (en) 2005-02-15
US6350284B1 (en) 2002-02-26

Similar Documents

Publication Publication Date Title
US6350284B1 (en) Bioabsorbable, layered composite material for guided bone tissue regeneration
US8740987B2 (en) Tissue-derived mesh for orthopedic regeneration
JP5430818B2 (en) Bioabsorbable porous reinforced tissue implant and method for producing the same
US6398814B1 (en) Bioabsorbable two-dimensional multi-layer composite device and a method of manufacturing same
US6319712B1 (en) Biohybrid articular surface replacement
AU2002320517B2 (en) Hybrid biologic-synthetic bioabsorable scaffolds
CA2327789C (en) Membrane with tissue-guiding surface corrugations
JP4302515B2 (en) Stand-alone surgical apparatus and method
US20100119564A1 (en) Guided bone regeneration membrane and manufacturing method thereof
EP1229858B1 (en) Biodegradable polymer/ceramic implant material with bimodal degradation profile
EP2204200A1 (en) Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
JP2019022651A (en) Bone implant for enclosing bone material
JP2005515802A (en) Hybrid / Synthetic Porous Extracellular Matrix Support Skeleton
WO2010099333A2 (en) Bone graft material containment structures
JP2007537778A (en) Graft scaffold in combination with self or allogeneic tissue
CA2718718A1 (en) Methods, devices and compositions for adhering hydrated polymer implants to bone
JP2007236802A (en) Material for implant inclination
EP3630214A1 (en) Resorbable crosslinked form stable membrane
JP4170744B2 (en) Biomaterial for artificial cartilage
JP3597313B2 (en) Vertebral body fixation member
Wiśniewska et al. Bioresorbable polymeric materials–current state of knowledge
US20220125998A1 (en) Membrane
JP2004121302A (en) Implant complex
EP1618903A1 (en) Hybrid biologic-synthetic bioabsorbable scaffolds
Linaritakis et al. The use of modern biomaterials in the reconstruction of orbital wall defects

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: B1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

B Later publication of amended claims
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999969010

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2343333

Country of ref document: CA

Ref country code: CA

Ref document number: 2343333

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 569738

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 59761/99

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1999969010

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 59761/99

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1999969010

Country of ref document: EP